Please assess the completion status of the following clinical trial:

Trial Title: Duloxetine for Acute Post-mastectomy Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Adult females scheduled for unilateral MRM with axillary evacuation for breast cancer,~* American Society of Anesthesiologists physical status (ASA) class I and II~Exclusion Criteria:~* Patients with a known allergy to Duloxetine or morphine,~* A history of drug or alcohol abuse,~* Patients with impaired kidney or liver functions,~* Patients with chronic pain or regularly receiving analgesics,~* Any psychiatric illness that would interfere with the perception and the assessment of pain.~* Any reason that resulted in the protocol violation.

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- placebo group (Type: PLACEBO_COMPARATOR): None
- duloxetine 30 (Type: ACTIVE_COMPARATOR): None
- duloxetine 60 (Type: ACTIVE_COMPARATOR): None
- duloxetine 90 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).